2 recruiting. 2 Phase 3.
| Phase | Trials | Status |
|---|---|---|
| Phase 3 | 2 | Recruiting 2 |
Follow ((18)F)PI-2620: new trials by email Literature Review of ((18)F)PI-2620 trials Research Report on ((18)F)PI-2620
Tick up to 5 trials to compare them side by side (eligibility, arms, endpoints, adverse events) in a Literature Matrix.
| Trial | Phase | Status | Sponsor | Enrollment | Start | Updated |
|---|---|---|---|---|---|---|
| [18F]PI-2620 Phase 3 Histopathological Study [18F]PI-2620 - Alzheimer Disease | Phase 3 | Recruiting | Lantheus Biosciences Ltd. | 200 | 2022-12-01 | 2026-10-23 |
| PET Imaging Tau Accumulation in FTLD and Atypical Alzheimer's Using [18F]-PI-2620 [18F]-PI-2620 - Frontotemporal Lobar Degeneration, Alzheimer Disease | Phase 3 | Recruiting | University of Pennsylvania | 72 | 2022-09-19 | 2026-09-21 |
Alzheimer Disease (2) · Frontotemporal Lobar Degeneration (1)
Lantheus Biosciences Ltd. (1) · University of Pennsylvania (1)
United States (2)
Alireza Atri, MD, PhD (1) · Andrew Stephens, MD, PhD (1) · Jeffrey S Phillips (1)